Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday. The company’s ...

The Wiskott-Aldrich syndrome protein (WASp) is expressed exclusively in hematopoietic cells and presents either an autoinhibited or activated conformation. EG-011 is a first-in-class activator of the ...

Research in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given ...

During the conference, Dr. Vera and members of the Marker management team will conduct one-on-one meetings with registered investors, showcasing the Company’s business and clinical development.

Roche said it will buy Poseida Therapeutics in a deal worth up to $1.5 billion, as the Swiss pharmaceutical giant seeks to ...

Swiss pharmaceutical giant Roche said on Tuesday it agreed to buy US biopharma firm Poseida Therapeutics for $1.5 billion ...

HanX Biopharmaceuticals is planning a Hong Kong listing to fund the phase 2 trial of its lead solid tumor drug. | HanX ...

In this randomized controlled trial, among adults diagnosed with chronic myeloid leukemia (CML), asciminib demonstrated a ...

The safety of left atrial appendage occlusion (LAAO) device implantation in patients with CKD has been uncertain and tied with complications.